nasopharyngeal carcinoma
Conditions
Interventions
Research group:No
Control group:No
Sponsors
Zhujiang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years; 2. ECOG performance status (PS) level 0-1; 3. Pathologically confirmed newly treated patients with nasopharyngeal carcinoma or patients with recurrent nasopharyngeal carcinoma after radiotherapy; 4. Subjects voluntarily joined the study and signed informed consent, with good compliance and follow-up.
Exclusion criteria
Exclusion criteria: 1. Known hereditary or acquired bleeding and thrombophilia (such as hemophilia patients, coagulopathy, thrombocytopenia, hypersplenism, etc.); 2. Long-term uncured wounds or fractures (except pathological fractures caused by tumors); 3. Major surgical operations or severe traumatic injuries, fractures or ulcers occurred within 4 weeks before enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whole exome sequencing;RNA-seq;Germline mutation detection; | — |
Countries
China
Contacts
Public ContactJian Zhang
Outcome results
None listed